4.0 Editorial Material

State of the art in computational modelling of cancer

出版社

OXFORD UNIV PRESS
DOI: 10.1093/imammb/dqr029

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer

Gunjan Mandal, Subir Biswas, Carmen M. Anadon, Xiaoqing Yu, Chandler D. Gatenbee, Sandhya Prabhakaran, Kyle K. Payne, Ricardo A. Chaurio, Alexandra Martin, Patrick Innamarato, Carlos Moran, John J. Powers, Carly M. Harro, Jessica A. Mine, Kimberly B. Sprenger, Kristen E. Rigolizzo, Xuefeng Wang, Tyler J. Curiel, Paulo C. Rodriguez, Alexander R. Anderson, Ozlen Saglam, Jose R. Conejo-Garcia

Summary: This study reveals the crucial role of humoral immunity in human endometrial cancer and provides insights for the development of novel immunotherapies against this prevalent malignancy. Coordinated cellular and humoral immune responses, particularly involving B cells and IgA:plgR interactions, determine the progression of endometrial cancer and its response to treatment.

CANCER RESEARCH (2022)

Article Biotechnology & Applied Microbiology

Fluctuating methylation clocks for cell lineage tracing at high temporal resolution in human tissues

Calum Gabbutt, Ryan O. Schenck, Daniel J. Weisenberger, Christopher Kimberley, Alison Berner, Jacob Househam, Eszter Lakatos, Mark Robertson-Tessi, Isabel Martin, Roshani Patel, Susan K. Clark, Andrew Latchford, Chris P. Barnes, Simon J. Leedham, Alexander R. A. Anderson, Trevor A. Graham, Darryl Shibata

Summary: Lineage tracing of human stem cells can be achieved by measuring fluctuating DNA methylation, which can serve as clocks that record cell ancestry. This study developed a mathematical model to quantitatively measure the dynamics of human adult stem cells using fluctuating DNA methylation marks. The results showed differences in the number and replacement speed of stem cells in different tissues, and also demonstrated the potential application of fluctuating methylation clocks in diseases.

NATURE BIOTECHNOLOGY (2022)

Article Biochemistry & Molecular Biology

Roadmap on plasticity and epigenetics in cancer

Jasmine Foo, David Basanta, Russell C. Rockne, Carly Strelez, Curran Shah, Kimya Ghaffarian, Shannon M. Mumenthaler, Kelly Mitchell, Justin D. Lathia, David Frankhouser, Sergio Branciamore, Ya-Huei Kuo, Guido Marcucci, Robert Vander Velde, Andriy Marusyk, Sui Huang, Kishore Hari, Mohit Kumar Jolly, Haralampos Hatzikirou, Kamrine E. Poels, Mary E. Spilker, Blerta Shtylla, Mark Robertson-Tessi, Alexander R. A. Anderson

Summary: This article focuses on the role of plasticity and epigenetics in cancer, and discusses state-of-the-art mathematical and experimental approaches to study these aspects. It addresses important questions about the integration of non-genetic plasticity and mutation-driven somatic evolution, the measurement and modeling of the microenvironment's role, experimental study of non-genetic plasticity, suitable mathematical techniques, as well as the clinical and practical applications and implications.

PHYSICAL BIOLOGY (2022)

Article Oncology

TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization

Alycia Gardner, Alvaro de Mingo Pulido, Kay Hanggi, Sarah Bazargan, Alexis Onimus, Agnieszka Kasprzak, Jose R. Conejo-Garcia, Katarzyna A. Rejniak, Brian Ruffell

Summary: Blocking TIM-3 increases exposure of intratumoral CD8(+) T cells to cytokines from cDC1s, with CXCL9 playing a critical role in this process.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Oncology

Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells

Carmen M. Anadon, Xiaoqing Yu, Kay Hanggi, Subir Biswas, Ricardo A. Chaurio, Alexandra Martin, Kyle K. Payne, Gunjan Mandal, Patrick Innamarato, Carly M. Harro, Jessica A. Mine, Kimberly B. Sprenger, Carla Cortina, John J. Powers, Tara Lee Costich, Bradford A. Perez, Chandler D. Gatenbee, Sandhya Prabhakaran, Douglas Marchion, Mirjam H. M. Heemskerk, Tyler J. Curiel, Alexander R. Anderson, Robert M. Wenham, Paulo C. Rodriguez, Jose R. Conejo-Garcia

Summary: This study reveals that tissue-resident memory (TRM) cells are the main type of T cells infiltrating ovarian cancer. These TRM cells, specifically the progenitor TRMstem cells, play a crucial role in predicting the outcome of ovarian cancer. The findings suggest that ovarian cancer is immunogenic, but only a small portion of tumor-infiltrating T cells have tumor antigen reactivity.

CANCER CELL (2022)

Article Biochemistry & Molecular Biology

Gattaca: Base-Pair Resolution Mutation Tracking for Somatic Evolution Studies using Agent-based Models

Ryan O. Schenck, Gabriel Brosula, Jeffrey West, Simon Leedham, Darryl Shibata, Alexander R. A. Anderson

Summary: Research in the past two decades has significantly advanced our understanding of somatic mutations, particularly in homeostatic tissue. The emergence of agent-based mechanistic models has provided a valuable tool for studying somatic mutations at base-pair resolution, with Gattaca being introduced as the first method for this purpose. By incorporating human reference genomes, mutational context, and sequence coverage/error information, Gattaca allows for realistic evolution of sequence data for comparison between in silico cell tissue modeling and experimental human somatic mutation data.

MOLECULAR BIOLOGY AND EVOLUTION (2022)

Article Multidisciplinary Sciences

Immunosuppressive niche engineering at the onset of human colorectal cancer

Chandler D. Gatenbee, Ann-Marie Baker, Ryan O. Schenck, Maximilian Strobl, Jeffrey West, Margarida P. Neves, Sara Yakub Hasan, Eszter Lakatos, Pierre Martinez, William C. H. Cross, Marnix Jansen, Manuel Rodriguez-Justo, Christopher J. Whelan, Andrea Sottoriva, Simon Leedham, Mark Robertson-Tessi, Trevor A. Graham, Alexander R. A. Anderson

Summary: Integration of mathematical modeling, ecological analyses, and neoantigen prediction suggests that recruitment of immunosuppressive cells is crucial for the transformation from adenoma to carcinoma in colorectal cancer. The dynamics of tumor initiation remain unknown, but the interaction between neoplastic cells and the immune system is believed to play a critical role in this process.

NATURE COMMUNICATIONS (2022)

Article Oncology

Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics

Jill Gallaher, Maximilian Strobl, Jeffrey West, Robert Gatenby, Jingsong Zhang, Mark Robertson-Tessi, Alexander R. A. Anderson

Summary: This study proposed a framework for estimating features of metastases through tumor response dynamics in patients with metastatic castration-resistant prostate cancer undergoing adaptive androgen deprivation treatment. The size of metastases, the proportion of drug-resistant cells, and the cell turnover rate were found to affect the treatment outcomes. The number of metastases, on the other hand, did not have an impact on the treatment cycle times.

CANCER RESEARCH (2023)

Editorial Material Oncology

Evolutionary Dynamics and Intermittent Therapy for Metastatic Cancers

Jad Chahoud, Alexander R. A. Anderson, Jingsong Zhang, Joel Brown, Robert A. Gatenby

JOURNAL OF CLINICAL ONCOLOGY (2023)

Meeting Abstract Oncology

Dynamics of fibril collagen remodeling in early DCIS invasions: integrating in silico modeling and tumor histology

Katarzyna A. Rejniak, Sharan Poonja, Shreya Mathur, Mehdi Damaghi, Marilyn Bui

CANCER PREVENTION RESEARCH (2022)

Meeting Abstract Oncology

Dynamics of fibril collagen remodeling in early DCIS invasions: integrating in silico modeling and tumor histology

Katarzyna A. Rejniak, Sharan Poonja, Shreya Mathur, Mehdi Damaghi, Marilyn Bui

CANCER PREVENTION RESEARCH (2022)

Meeting Abstract Oncology

Evolutionary Tumor Board: Implementing dynamic personalized therapy using evolutionary theory and mathematical modeling for clinical decision support

Mark Robertson-Tessi, Joel Brown, Maria Poole, Kimberly Luddy, Andriy Marusyk, Jill Gallaher, Jeffrey West, Matthew Johnson, Heiko Enderling, Rikesh Makanji, Joaquim Farinhas, Robert Gatenby, Damon Reed, Christine Chung, Alexander Anderson

CANCER RESEARCH (2022)

Meeting Abstract Oncology

Mutation agnostic diagnosis of clonal hematopoiesis of indeterminate potential (CHIP) using fluctuating methylation clocks

Ryan O. Schenck, Niels Asger Jakobsen, Virginia Turati, Darryl Shibata, Paresh Vyas, Simon Leedham, Alexander R. A. Anderson

CANCER RESEARCH (2022)

Meeting Abstract Oncology

Integrating mathematical modelling and wet-lab experiments to examine the scope for adaptive treatment scheduling of PARP inhibitors in ovarian cancer

Maximilian Strobl, Mehdi Damaghi, Alexandra Martin, Samantha Byrne, Mark Robertson-Tessi, Robert Gatenby, Robert Wenham, Philip Maini, Alexander R. A. Anderson

CANCER RESEARCH (2022)

Article Medicine, Research & Experimental

Spatial structure impacts adaptive therapy by shaping intra-tumoral competition

Maximilian A. R. Strobl, Jill Gallaher, Jeffrey West, Mark Robertson-Tessi, Philip K. Maini, Alexander R. A. Anderson

Summary: This theoretical study investigates the intra-tumoral competition during adaptive therapy and finds that adaptive therapy is superior to aggressive treatment in suppressing resistance. The study reveals that competition among resistant cells plays a crucial role in adaptive therapy in solid tumors.

COMMUNICATIONS MEDICINE (2022)

暂无数据